Your browser doesn't support javascript.
loading
Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD.
Vilorio-Marqués, Laura; Castañón Fernández, Christelle; Mora, Elvira; Gutiérrez, Lorena; Rey Bua, Beatriz; Jiménez Lorenzo, Maria José; Díaz Beya, Marina; Vara Pampliega, Miriam; Molero, Antonieta; Sánchez-García, Joaquín; Calabuig, Marisa; Cedena, Maria Teresa; Chen-Liang, Tzu; Díaz Santa, Johana Alejandra; Padilla, Irene; Hernández, Francisca; Díez, Rosana; Asensi, Pedro; Xicoy, Blanca; Sanz, Guillermo; Valcárcel, David; Diez-Campelo, María; Bernal, Teresa.
Affiliation
  • Vilorio-Marqués L; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
  • Castañón Fernández C; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
  • Mora E; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Gutiérrez L; Hematology Department, Hospital Universitario de Canarias, La Laguna, Spain.
  • Rey Bua B; Hematology Department, Hospital Clínico Universitario, Salamanca, Spain.
  • Jiménez Lorenzo MJ; Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia-Josep Carreras, Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Díaz Beya M; Hematology Department, Hospital Clínico Barcelona, Barcelona, Spain.
  • Vara Pampliega M; Hematology Department, Hospital Universitario Cruces, Barakaldo, Spain.
  • Molero A; Hematology Department, Hospital Universitari Vall d'Hebrón, Barcelona, Spain.
  • Sánchez-García J; Hematology Department, Hospital Universitario Reina Sofía, Cordoba, Spain.
  • Calabuig M; Hematology Department, Hospital Clínico de Valencia, Valencia, Spain.
  • Cedena MT; Hematology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
  • Chen-Liang T; Hematology Department, Hospital Universitario Morales Messeguer, Murcia, Spain.
  • Díaz Santa JA; Hematology Department, Institut Catalá de Oncología, Girona, Spain.
  • Padilla I; Hematology Department, Complejo Asistencial Universitario de León, Castilla y León, Spain.
  • Hernández F; Hematology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Díez R; Hematology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Asensi P; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Xicoy B; Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia-Josep Carreras, Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Sanz G; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Valcárcel D; Hematology Department, Hospital Universitari Vall d'Hebrón, Barcelona, Spain.
  • Diez-Campelo M; Hematology Department, Hospital Clínico Universitario, Salamanca, Spain.
  • Bernal T; Hematology Department, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias.
Ther Adv Hematol ; 13: 20406207221127547, 2022.
Article in En | MEDLINE | ID: mdl-36199837
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Language: En Journal: Ther Adv Hematol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Language: En Journal: Ther Adv Hematol Year: 2022 Document type: Article Affiliation country: Country of publication: